Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helicobacter Pylori Screening and Treatment in South Florida
NCT07224035Phase 4Completed
- Sponsor
- University of Miami
- Start
- Oct 2022
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vonoprazan in Helicobacter pylori infection, sponsored by University of Miami. Started Oct 2022; status: completed.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07224035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07224035.